IL1B and freckles: We consistently observed that AOPT‐LTL treatment significantly reduced mast cell infiltration and the release of pro‐inflammatory cytokines (TNF‐α, IL‐1β, IL‐6) and the expression of key enzymes regulating inflammatory mediators (iNOS, COX‐2) in a guinea pig model of melasma.